Browse Articles

Sex differences in confidence and memory

Primack et al. | Oct 25, 2021

Sex differences in confidence and memory

In this work, the authors sought to provide an original experiment to investigate the conflict over whether males or females tend to exhibit greater accuracy or confidence in their memories. By using an online portal to obtain a convenience sample, the authors found that their results suggest that though males tend to be more confident regarding their memories, they may in fact remember fewer details. The authors suggest that these findings merit further research before making systematic changes regarding crime scene recall settings.

Read More...

The study of technology and the use of individual cognitive effort

Neravetla et al. | Jan 24, 2023

The study of technology and the use of individual cognitive effort
Image credit: Glenn Carstens-Peters

A trial study was performed in 2021 to investigate the link between technology and transactive memory. Transactive memory is shared knowledge in which members share the responsibility to encode, store, and retrieve certain tasks or assignments, leading to a successful and collective performance. We hypothesize that a participants’ expected access to an external source affects the recall rate and retrieval of information.

Read More...

Diagnosing hypertrophic cardiomyopathy using machine learning models on CMRs and EKGs of the heart

Kolluri et al. | Jul 29, 2024

Diagnosing hypertrophic cardiomyopathy using machine learning models on CMRs and EKGs of the heart
Image credit: Jesse Orrico

Here seeking to develop a method to diagnose, hypertrophic cardiomyopathy which can cause sudden cardiac death, the authors investigated the use of a convolutional neural network (CNN) and long short-term memory (LSTM) models to classify cardiac magnetic resonance and heart electrocardiogram scans. They found that the CNN model had a higher accuracy and precision and better other qualities, suggesting that machine learning models could be valuable tools to assist physicians in the diagnosis of hypertrophic cardiomyopathy.

Read More...

Prediction of preclinical Aβ deposit in Alzheimer’s disease mice using EEG and machine learning

Igarashi et al. | Nov 29, 2022

Prediction of preclinical Aβ deposit in Alzheimer’s disease mice using EEG and machine learning

Alzheimer’s disease (AD) is a common disease affecting 6 million people in the U.S., but no cure exists. To create therapy for AD, it is critical to detect amyloid-β protein in the brain at the early stage of AD because the accumulation of amyloid-β over 20 years is believed to cause memory impairment. However, it is difficult to examine amyloid-β in patients’ brains. In this study, we hypothesized that we could accurately predict the presence of amyloid-β using EEG data and machine learning.

Read More...

A Novel Alzheimer's Disease Therapeutic Model: Attenuating Hyperphosphorylated Tau and Amyloid β (Aβ) Aggregates by Characterizing Antioxidative, Anti-Inflammatory, and Neuroprotective Properties of Natural Extracts

Pokkunuri et al. | Jul 25, 2022

A Novel Alzheimer's Disease Therapeutic Model: Attenuating Hyperphosphorylated Tau and Amyloid β (Aβ) Aggregates by Characterizing Antioxidative, Anti-Inflammatory, and Neuroprotective Properties of Natural Extracts

Oxidative damage and neuro-inflammation were the key pathways implicated in the pathogenesis of Alzheimer’s disease. In this study, 30 natural extracts from plant roots and leaves with extensive anti-inflammatory and anti-oxidative properties were consumed by Drosophila melanogaster. Several assays were performed to evaluate the efficacy of these combinational extracts on delaying the progression of Alzheimer’s disease. The experimental group showed increased motor activity, improved associative memory, and decreased lifespan decline relative to the control group.

Read More...

Herbal Extracts Alter Amyloid Beta Levels in SH-SY5Y Neuroblastoma Cells

Xu et al. | Feb 25, 2020

Herbal Extracts Alter Amyloid Beta Levels in SH-SY5Y Neuroblastoma Cells

Alzheimer’s disease (AD) is a type of dementia that affects more than 5.5 million Americans, and there are no approved treatments that can delay the advancement of the disease. In this work, Xu and Mitchell test the effects of various herbal extracts (bugleweed, hops, sassafras, and white camphor) on Aβ1-40 peptide levels in human neuroblastoma cells. Their results suggest that bugleweed may have the potential to reduce Aβ1-40 levels through its anti-inflammatory properties.

Read More...